Lung lymphomas: the range of available therapeutic solutions
Severe asthma: results of the ANANCHE real‑life study on benralizumab
it
Prof. Giorgio Walter Canonica
ERS–EULAR guidelines on interstitial lung disease associated with connective tissue disease
en
Prof. Bruno Crestani
Evidence on risk factors for idiopathic pulmonary fibrosis
it
Prof. Isabella Annesi Maisano
Cardiovascular comorbidities and the use of biologics in COPD patients
it
Prof. Antonio Spanevello
Chronic Rhinosinusitis with Nasal Polyps: The Efficacy of New Biological Drugs
en
Prof. Enrico Marco Heffler
Lung lymphomas: the range of available therapeutic solutions
it
Prof. Venerino Poletti
Respiratory diseases: preventing avoidable risk factors
it
Dr. Giovanni Viegi
Raise awareness of the risks of pollutants to children's respiratory health
it
Dr. Stefania La Grutta
Pulmonary Arterial Hypertension: Understanding Today’s Patient Population
Dr Luke S. Howard
Use of home telemedicine in mechanical ventilation. ERS guidelines.
it
Prof. Claudia Crimi
Airway Fungal Infections: Insights from Clinical Cases
en
Prof. Eva Van Braeckel
Chronic Respiratory Failure: Telemonitoring and Telemedicine to Improve Treatment
en
Dr. Maxime Patout
Impact of air quality on health: WHO commitment
en
Sophie Gumy
European Lung Foundation, a reference for patients with respiratory diseases
en
Pippa Powell